Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Quest Diagnostics Inc reaffirms FY 2014 guidance


Thursday, 24 Apr 2014 07:03am EDT 

Quest Diagnostics Inc:Says that FY 2014 revenue and adjusted earnings per diluted share guidance is unchanged.Expects FY 2014 revenues to increase 2 pct. to 4 pct. compared to prior year.Expects FY 2014 adjusted earnings per diluted share (EPS) to be between $3.95 and $4.15.Reported revenue of $7.146 bln in FY 2013.FY 2014 revenue of $7.322 bln and EPS of $4.04 - Thomson Reuters I/B/E/S. 

Related Company News

Company Quote

67.78
-0.16 -0.24%
26 Dec 2014